Grantee Spotlight: Covenant Health & ABHOP

This month, we continue to highlight the great work of our Community Grant recipients. These are the organizations who, after meeting eligibility requirements and a….

Susan G. Komen Unveils $26 Million Investment in Research Focused on Metastatic Breast Cancer and New Treatments

FOR IMMEDIATE RELEASE Sean Tuffnell Susan G. Komen® 972-855-4382 Hannah Beaty Komen North and West Texas 972-372-0172   SUSAN G. KOMEN® UNVEILS $26….

Susan G. Komen® Advocates to Remove Cost Barriers

Susan G. Komen North & West Texas has worked for the last 29 years to ensure Texas women have access to life-saving breast cancer screening,….

Grantee Spotlight: Bridge Breast Network and Harrington Cancer and Health Foundation

Meet Our Grantees This month, we are excited to begin a monthly series that will feature all of the grantees from the newly merged service….

Here’s what you need to know about clinical trials

Clinical trials test the safety and benefits of new treatments as well as new combinations or new doses of standard treatments.  They can also study….

Introducing Komen North & West Texas

Susan G. Komen® North Texas (based in Plano, Texas) and Susan G. Komen® West Texas (based in Amarillo and Lubbock) announced today that they are….

National Advocacy – Komen Goes to Washington, D.C.

From May 1-3, Susan G. Komen Headquarters hosted the 2019 Advocacy Summit in Washington, D.C. to prepare approximately 300 Affiliate staff, Board members, volunteers, survivors,….

Our Grant Making Process and 2019-2020 Grantees

ABOUT THE GRANT-MAKING PROCESS Grant-making is the primary activity by which we invest in our community while ensuring quality, consistency, and transparency during the process. ….

Advocacy in Austin

Susan G. Komen is the voice for the more than 3.1 million breast cancer survivors living in the United States and those who love them,….

Do You Know Your Girls?

African American women are 40% more likely to die from breast cancer than white women, are often diagnosed at later stages when treatments are limited,….